EPHX2 and metabolic dysfunction-associated steatohepatitis: Previous studies have shown altered AA metabolites in NASH patients, reduced CYP2J2 expression in high-fat diet (HFD)-induced NASH mice (26), decreased EETs (15), and increased sEH (32) in NASH mice.